Detalhe da pesquisa
1.
Long-term effectiveness of eptinezumab in patients with migraine and prior preventive treatment failures: extension of a randomized controlled trial.
J Headache Pain
; 24(1): 155, 2023 Nov 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-37985968
2.
Effect of antibody switch in non-responders to a CGRP receptor antibody treatment in migraine: A multi-center retrospective cohort study.
Cephalalgia
; 42(4-5): 291-301, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-34644203
3.
Erenumab versus topiramate for the prevention of migraine - a randomised, double-blind, active-controlled phase 4 trial.
Cephalalgia
; 42(2): 108-118, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34743579
4.
Comparing the relative and absolute effect of erenumab: is a 50% response enough? Results from the ESTEEMen study.
J Headache Pain
; 23(1): 38, 2022 Mar 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-35305579
5.
Real-life use of onabotulinumtoxinA reduces healthcare resource utilization in individuals with chronic migraine: the REPOSE study.
J Headache Pain
; 22(1): 50, 2021 Jun 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34078259
6.
Shift from high-frequency to low-frequency episodic migraine in patients treated with Galcanezumab: results from two global randomized clinical trials.
J Headache Pain
; 22(1): 48, 2021 May 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-34049484
7.
Peripheral nerve stimulation registry for intractable migraine headache (RELIEF): a real-life perspective on the utility of occipital nerve stimulation for chronic migraine.
Acta Neurochir (Wien)
; 162(12): 3201-3211, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32377948
8.
Epidemiology, Demographics, Triptan Contraindications, and Prescription Patterns of Patients with Migraine: A German Claims Database Study.
Neurol Ther
; 11(1): 167-183, 2022 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-34837636
9.
A Digital Therapeutic Allowing a Personalized Low-Glycemic Nutrition for the Prophylaxis of Migraine: Real World Data from Two Prospective Studies.
Nutrients
; 14(14)2022 Jul 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-35889884
10.
A Digital Health Application Allowing a Personalized Low-Glycemic Nutrition for the Prophylaxis of Migraine: Proof-of-Concept Data from a Retrospective Cohort Study.
J Clin Med
; 11(4)2022 Feb 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-35207390
11.
Relevant factors for neurologists to define effectiveness of migraine preventive drugs and take decisions on treatment. My-LIFE European Delphi survey.
Eur J Pain
; 25(10): 2177-2189, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34173301
12.
Gender Differences in 3-Month Outcomes of Erenumab Treatment-Study on Efficacy and Safety of Treatment With Erenumab in Men.
Front Neurol
; 12: 774341, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34975732
13.
Triptan efficacy does not predict onabotulinumtoxinA efficacy but improves with onabotulinumtoxinA response in chronic migraine patients.
Sci Rep
; 10(1): 11382, 2020 07 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32647152
14.
Erenumab in Chronic Migraine Patients Who Previously Failed Five First-Line Oral Prophylactics and OnabotulinumtoxinA: A Dual-Center Retrospective Observational Study.
Front Neurol
; 11: 417, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32547474
15.
Part I: what do patients really need and want from migraine treatment?
Curr Med Res Opin
; 21 Suppl 3: S3-7, 2005.
Artigo
em Inglês
| MEDLINE | ID: mdl-16083517
16.
Part IV: effects of zolmitriptan orally disintegrating tablet on migraine symptoms and ability to perform normal activities: a post-marketing surveillance study in Germany.
Curr Med Res Opin
; 21 Suppl 3: S18-24, 2005.
Artigo
em Inglês
| MEDLINE | ID: mdl-16083520
17.
Migraine treatment strategies: the global Migraine And Zolmitriptan Evaluation (MAZE) survey--phase IV.
Curr Med Res Opin
; 20(11): 1777-83, 2004 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-15537478
18.
Topiramate for migraine prevention in adolescents: a pooled analysis of efficacy and safety.
Headache
; 46(10): 1503-10, 2006.
Artigo
em Inglês
| MEDLINE | ID: mdl-17115983
19.
Almotriptan in migraine patients who respond poorly to oral sumatriptan: a double-blind, randomized trial.
Eur Neurol
; 53 Suppl 1: 41-8, 2005.
Artigo
em Inglês
| MEDLINE | ID: mdl-15920337
20.
Almotriptan in migraine patients who respond poorly to oral sumatriptan: a double-blind, randomized trial.
Headache
; 45(7): 874-82, 2005.
Artigo
em Inglês
| MEDLINE | ID: mdl-15985104